drugset / Trial / NCT01222442

To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart

NCT01222442

Phase 1 Completed 40 enrolled AstraZeneca
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this research study is to evaluate the effect of AZD3199 on the electrical activity of the heart. The effect of AZD3199 will be compared to a licensed antibiotic (moxifloxacin). Moxifloxacin effects on the electrical activity of the heart are well known. Safety and tolerability of AZD3199 and how much AZD3199 enters the blood circulation will also be assessed.

Timeline

Start
2010-11
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD3199 Unknown 400 ug Inhaled
Subject AZD3199 Unknown 1200 ug Inhaled
Comparator Moxifloxacin Small molecule 400 mg Oral